Cancer

Inside cells, protein factories called ribosomes have a unique way of patching oxidative stress damage, according to a new discovery from the Karbstein lab.

A bioresponsive sensor from Carroll lab activates antioxidants only when needed and provides a tool for studying free radicals' role in disease.

Glioblastoma is fast-moving, and the most common type of brain cancer. Two specific cancer cell mutations may work together to help hide these tumors from the immune system, a study from Janiszewska finds.

A team led by chemistry professor Ben Shen, Ph.D., discovered a potent anti-cancer compound within the institute's natural products collection. It has been connected to a precise cancer-seeking antibody with an innovative linker molecule.

Florida’s statewide biotechnology industry organization, BioFlorida, awarded its 2022 Weaver H. Gaines Entrepreneur of the Year award to Courtney Miller, Ph.D.

Enediynes can bind and break DNA, leading to cell death. As a result, they have enormous potential as antibiotics and cancer drugs. A new study reveals how nature assembles them.

Two scientists at UF Scripps have been recognized with "Invention of the Year" awards from UF Innovate. Read about their inventions.

A trailblazing scientist targets ALS, myotonic dystrophy, Parkinson’s, metastatic breast cancer, viral diseases and more by attacking key RNA, preventing disease-causing genes from being expressed in the first place.

The findings show it is possible to substantially accelerate the drug discovery process. The technique opens new doors to treating diseases by targeting their RNA processes, said Disney.

The Karbstein lab has discovered how ribosomes are remodeled in response to stress, altering their protein output.